Called the “master antioxidant,” glutathione is an amino acid found in every cell in the body that plays a key role in immune health, the body’s detoxification process, and more.
Photo © iStockphoto.com/Eraxion
Kyowa Hakko (New York City) announced it has now launched its Setria glutathione brand in European markets. It is already sold in the United States and Asia.
Called the “master antioxidant,” glutathione is an amino acid found in every cell in the body that plays a key role in immune health, the body’s detoxification process, and more. The body produces glutathione naturally, but its glutathione stores can decline due to lifestyle choices, stress, and the natural aging process.
Kyowa Hakko’s Setria glutathione is described as a unique tripeptide consisting of three key amino acids: glutamic acid, cysteine, and glycine. The company produces it using a patented fermentation process, a process that the firm says “further distinguishes Setria glutathione from generic glutathione in the market.”
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine
jennifer.grebow@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.